Skip to content

Elevance Health ELV Cash & Equivalents

Cash & Equivalents at other companies

Humana logo
HumanaHUM
$6.89B+70.6%
CVS Health logo
CVS HealthCVS
$9.77B-5.6%
UnitedHealth Group logo
UnitedHealth GroupUNH
$28B-8.8%
Centene logo
CenteneCNC
$24.15B+66.4%
Molina Healthcare logo
Molina HealthcareMOH
$4.99B+10.8%
Oscar Health logo
Oscar HealthOSCR
$4.83B+114%

Other financials

Income statement

See full
Revenue$50.5B+1.4%
Gross profit$45.0B+1.1%
Net income$1.5B-16.1%
EPS (diluted)$6.71-13.1%

Balance sheet

See full
Total debt$30.7B+7.5%
Total equity$44.9B+2.7%
Total assets$126.44B+3.7%

Cash flow

See full
Operating cash flow$1.9B-6.9%
CapEx$287.0M+7.5%
Free cash flow$1.6B-9.0%

Valuation

See full
Market cap$81.63B+28.1%
Enterprise value$102.07B+21.9%
P/E16.5×+4.6×
P/S0.4×+0.1×

Profitability

See full
Gross margin89.1%+0.4pp
Net margin2.5%-0.4pp
FCF margin3.2%+0.4pp

Returns & leverage

See full
Return on equity11.2%-1.3pp
Debt / equity0.7×0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Elevance Health in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Elevance Health’s 10-Q, filed July 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elevance Health's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Elevance Health's cash & equivalents?
Elevance Health (ELV) reported cash & equivalents of $10.23B in Q2 2026.
How has Elevance Health's cash & equivalents changed year-over-year?
Elevance Health's cash & equivalents increased by 19.5% year-over-year, from $8.56B to $10.23B.
What is the long-term trend for Elevance Health's cash & equivalents?
Over 5 years (2020 to 2025), Elevance Health's cash & equivalents has grown at a 10.6% compound annual growth rate (CAGR), from $5.74B to $9.49B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.